申请人:Song Jiangao
公开号:US20120184572A1
公开(公告)日:2012-07-19
Aryl GPR119 agonists are provided. These compounds are useful for the treatment of diabetic diseases, including Type II diabetes and other diseases associated with poor glycemic control.
提供了芳基GPR119激动剂。这些化合物对于治疗糖尿病等疾病非常有用,包括II型糖尿病和其他与血糖控制不佳有关的疾病。